Cempra, Inc. to Report Third Quarter 2013 Financial and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cempra, Inc. to Report Third Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on Oct. 29, 2013

CHAPEL HILL, N.C., Oct. 22, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq: CEMP ) today announced that it will report third quarter 2013 financial results and provide a business update after the close of U.S. financial markets on Oct. 29, 2013. Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra will host a conference call and webcast at 4:30 p.m. EDT, Oct. 29, 2013.

The conference call may be accessed by dialing 877-377-7553 for domestic callers and 253-237-1151 for international callers. Please specify to the operator that you would like to join the "Cempra, Inc., Third Quarter 2013 Financial Results Call, conference ID#: 81676336." The conference call will be webcast live under the investor relations section of Cempra's website at www.cempra.com , and will be archived there for 30 days following the call. Please visit Cempra's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Cempra, Inc.

Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin (CEM-101) is in a Phase 3 clinical trial for community-acquired bacterial pneumonia (CABP) and is licensed to strategic partner Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation, for certain exclusive rights in Japan. TAKSTA™ (CEM-102) is Cempra's second product candidate, which is currently in a Phase 2 clinical trial for prosthetic joint infections. Both seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about Cempra can be found at www.cempra.com .

Investor and Media Contacts: Robert E. Flamm, Ph.D. Russo Partners, LLC (212) 845-4226 Andreas Marathovouniotis Russo Partners, LLC (212) 845-4235

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 7

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 4

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 4

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 0

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 2

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 2

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 3

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 4

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 3

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 4

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading

Top 5 Most Recently Viewed Articles

Yesway Expands Reach with New Allsup's Stores Opening

Updated Category News Views 166

Yesway Takes Significant Steps in Store Expansion Yesway, a prominent player in the convenience retail sector, is rapidly expanding its network by introducing four new Allsup's stores in key regions. This strategic move marks another milestone in Yesway's commitment to growing its business and enhancing customer experiences. New Stores in Promising Markets The recent...

Continue Reading
IR Spectroscopy Market Growth: Projected USD 2 Billion by 2032

Updated Category News Views 171

IR Spectroscopy Market Insights and Future Growth Growing trends in technology and application expansion are driving significant changes in the IR spectroscopy market, which was valued at USD 1.3 billion recently. This market is projected to surpass USD 2 billion by the end of this decade. One of the primary contributors to this growth is the miniaturization and...

Continue Reading
Flow Capital Expands Investment in MiniLuxe's Growth Journey

Updated Category News Views 142

Flow Capital Expands Investment in MiniLuxe Flow Capital Corp. (TSXV:FW), a prominent player in providing alternative debt solutions and flexible growth capital, has reaffirmed its commitment to MiniLuxe Holding Corp. (TSXV: MNLX) with a substantial follow-on investment of US$1.675 million. This marks the third investment from Flow Capital into MiniLuxe, bringing the...

Continue Reading
Exploring the Expansive Pipeline of NLRP3 Protein Inhibitors

Updated Category News Views 326

An Overview of NLRP3 Protein Inhibitors The NLRP3 protein inhibitors are paving the way for new therapeutic avenues aimed at mitigating chronic inflammatory conditions. This approach targets a significant piece of the innate immune system, specifically the NOD-like receptor family pyrin domain-containing 3 (NLRP3), known for its involvement in myriad diseases. These...

Continue Reading
Sanara MedTech Engages Investors at Key Healthcare Conference

Updated Category News Views 106

Sanara MedTech's Participation at Major Healthcare Conference Sanara MedTech Inc. (Nasdaq: SMTI), a leader in medical technology, is excited to announce its upcoming participation in a significant healthcare conference held at The Lotte New York Palace. This event showcases innovative advancements aimed at enhancing surgical outcomes and addressing healthcare costs,...

Continue Reading